Carlos Ramos

15PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumoursModelling and simulationRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Dec 25, 2023
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.

LaQuisa C Hill, Rayne H Rouce, Mengfen J Wu

|Jan 11, 2023
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.

Thomas Pfeiffer, Ifigeneia Tzannou, Mengfen Wu

|Mar 24, 2022
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.

David H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill

|Mar 23, 2022
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion.

Leila Amini, Sara K Silbert, Shannon L Maude

|Mar 18, 2022
In vitro machine learning-based CAR T immunological synapse quality measurements correlate with patient clinical outcomes.

Alireza Naghizadeh, Wei-Chung Tsao, Jong Hyun Cho

|Feb 02, 2022
Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma.

Brian D Friend, Ibrahim N Muhsen, Shreeya Patel

Pageof 3

Frequent Collaborators

7 joint publications

Helen E Heslop

7 joint publications

Premal Lulla

4 joint publications

Tao Wang

4 joint publications

LaQuisa Hill